Lupin Limited launches Turqoz Tablets in US, aims to expand contraceptive market
Global pharmaceutical giant Lupin Limited has made a significant entry into the U.S. contraceptive market with the launch of Turqoz (Norgestrel and Ethinyl Estradiol) Tablets USP, 0.3 mg/0.03 mg. This follows the company’s successful receipt of approval from the United States Food and Drug Administration (U.S. FDA). Turqoz: A Generic Equivalent to Lo/Ovral-28 Turqoz is […]